GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Net Income Attributable to Noncontrolling Interests (2012 - 2014)

Updated

GT Biopharma's Net Income Attributable to Noncontrolling Interests was -$16,000 in FY2014, compared with -$63,000 in FY2013.

Analysis

GT Biopharma (GTBP) Net Income Attributable to Noncontrolling Interests (2012 - 2014) Analysis & Trends

  • Per Business Quant data, Net Income Attributable to Noncontrolling Interests in earlier years was -$63,000 in FY2013 and -$90,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 2.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 10.00 Mn
10 GT Biopharma 6.65 Mn -16.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 1,000.00
Jun 30, 2014 -1,000.00
Mar 31, 2014 1,000.00
Dec 31, 2013 -12,000.00
Sep 30, 2013 -46,000.00
Jun 30, 2013 -46,000.00
Mar 31, 2013 14,000.00
Dec 31, 2012 -62,000.00
Sep 30, 2012 -15,000.00
Jun 30, 2012 -13,000.00
API Access

GT Biopharma Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=GTBP&period=max&api_key=YOUR_API_KEY